Cyanotype Bio

What it does

Consumer and pharma supply chains are threatened by ecosystem loss and petrochemical dependence, with 97% of plant bioactives still untapped. Our AI-driven discovery and biomanufacturing platform unlocks novel ingredients using plant cell fermentation, displacing petrochemical production and wild harvests. Our founding team is backed by YC and Collab Fund, with our first LOI from a $B personal care brand and F500 negotiations underway. We’re protecting biodiversity and decarbonizing supply chains with the next generation of ingredients.